500 related articles for article (PubMed ID: 11120923)
21. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia.
Sampaio AM; Thomasini RL; Guardia AC; Stucchi RS; Rossi CL; Costa SC; Boin IF
Transplant Proc; 2011 May; 43(4):1357-9. PubMed ID: 21620128
[TBL] [Abstract][Full Text] [Related]
23. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.
Paya CV; Wilson JA; Espy MJ; Sia IG; DeBernardi MJ; Smith TF; Patel R; Jenkins G; Harmsen WS; Vanness DJ; Wiesner RH
J Infect Dis; 2002 Apr; 185(7):854-60. PubMed ID: 11920308
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
Humar A; Kumar D; Boivin G; Caliendo AM
J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
[TBL] [Abstract][Full Text] [Related]
25. Development of the loop-mediated isothermal amplification method for rapid detection of cytomegalovirus DNA.
Suzuki R; Yoshikawa T; Ihira M; Enomoto Y; Inagaki S; Matsumoto K; Kato K; Kudo K; Kojima S; Asano Y
J Virol Methods; 2006 Mar; 132(1-2):216-21. PubMed ID: 16289345
[TBL] [Abstract][Full Text] [Related]
26. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.
DesJardin JA; Cho E; Supran S; Gibbons L; Werner BG; Snydman DR
Clin Infect Dis; 2001 Oct; 33(8):1358-62. PubMed ID: 11565077
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients.
Ljungman P; Dahl H; Xu YH; Larsson K; Brytting M; Linde A
Bone Marrow Transplant; 2007 Apr; 39(8):497-9. PubMed ID: 17334385
[TBL] [Abstract][Full Text] [Related]
28. Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation.
Costa C; Delsedime L; Solidoro P; Curtoni A; Bergallo M; Libertucci D; Baldi S; Rinaldi M; Cavallo R
Transplant Proc; 2010 May; 42(4):1270-4. PubMed ID: 20534278
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
[TBL] [Abstract][Full Text] [Related]
30. Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women.
Broccolo F; Cassina G; Chiari S; Garcia-Parra R; Villa A; Leone BE; Brenna A; Locatelli G; Mangioni C; Cocuzza CE
J Med Virol; 2008 Jan; 80(1):147-53. PubMed ID: 18041029
[TBL] [Abstract][Full Text] [Related]
31. Detection and monitoring of human herpesvirus 7 in adult liver transplant patients: impact on clinical course and association with cytomegalovirus.
Thomasini RL; Sampaio AM; Bonon SH; Boin IF; Leonardi LS; Leonardi M; Costa SC
Transplant Proc; 2007 Jun; 39(5):1537-9. PubMed ID: 17580183
[TBL] [Abstract][Full Text] [Related]
32. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation.
Sampaio AM; Guardia AC; Milan A; Sasaki AN; Andrade PD; Bonon SH; Stucchi RS; Botelho Costa SC; Boin IF
Transplant Proc; 2012 Oct; 44(8):2455-8. PubMed ID: 23026619
[TBL] [Abstract][Full Text] [Related]
33. Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation.
Chapenko S; Trociukas I; Donina S; Chistyakov M; Sultanova A; Gravelsina S; Lejniece S; Murovska M
J Med Virol; 2012 Dec; 84(12):1953-60. PubMed ID: 23080502
[TBL] [Abstract][Full Text] [Related]
34. Risk of transmission of herpesviruses through cord blood transplantation.
Weinberg A; Enomoto L; Li S; Shen D; Coll J; Shpall EJ
Biol Blood Marrow Transplant; 2005 Jan; 11(1):35-8. PubMed ID: 15625542
[TBL] [Abstract][Full Text] [Related]
35. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
36. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
[TBL] [Abstract][Full Text] [Related]
37. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
